Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease

Richard Y. Davies, STABILITY Investigators, Philip E. Aylward

Research output: Contribution to journalArticle

33 Citations (Scopus)

Fingerprint Dive into the research topics of 'Lipoprotein-associated phospholipase A<sub>2</sub> activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease'. Together they form a unique fingerprint.

Medicine & Life Sciences